News & Media
Based in Danvers, Massachusetts, USA, Abiomed, Inc. (NASDAQ: ABMD) is a leading provider of medical devices that provide circulatory and respiratory support. Our cardiac products are designed to enable the heart to rest and recover by improving blood flow and/or performing the pumping of the heart. Our easy-to-use respiratory product is designed to oxygenate the blood, while promoting mobility.
Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients
June 1, 2021
Abiomed Announces Record Revenue of $241 Million, up 17% Year Over Year, With 26.0% Operating Margin
April 29, 2021
Impella® Heart Pumps
Impella heart pumps are the only U.S. Food and Drug Administration-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI or treatment of AMI cardiogenic shock. Impella has the unique ability to enable your heart to recover, allowing patients to return home from the hospital with their native hearts.
Abiomed Breethe OXY-1 System™ is an easy-to-use, compact cardiopulmonary support system, with an integrated oxygen concentrator that provides an independent oxygen source designed to support mobility.
Patient Stories of Heart Recovery
Our patients are the motivation for all that we do, and we take great joy in celebrating every patient’s success story. Explore the unique stories of people with complex heart disease and advanced heart failure who were able to recover their own hearts.